Definitive Healthcare Q1 revenue $63.5M (+7% YoY); Adj. EBITDA margin 32%; $20M buyback

Definitive Healthcare Corp.

2024-Q1 EPS reported -$0.08 revenue$63,480,000

Revenue $63.5M, +7% YoY from $59.2M; net loss narrowed to $12.7M from $16.0M.
Adjusted Net Income $13.0M vs $9.1M; Adjusted EBITDA $20.0M (32% margin vs 26%).
Enterprise customers grew 6% YoY to 559; added 30 clients with >$100K ARR.
Board authorized $20M stock repurchase program through end of 2024.
FY2024 guidance: revenue $255-$261M (+1-4%); Q2 revenue $62-$63.5M (+2-4%).

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.99

Definitive Healthcare Corp. reported first quarter ended March 31, 2024 results: revenue $63.5 million, net income $(12.7) million.

Period: first quarter ended March 31, 2024
Revenue: $63.5 million
Net income: $(12.7) million
Result: reported results

Exact text from the filing

EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2024 First quarter revenue grew 7% year-over-year to $63.5 million Framingham, MA (May 7, 2024) – Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence,

View on SEC.gov

708 earnings releases filed in the last 30 days. Browse all earnings releases →

Definitive Healthcare Corp. filing history →

Source: SEC EDGAR

accession 0000950170-24-054479

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.